Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its access have become key topics for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant barrier to many. Negot